Hartmut Döhner

4 ta ish

University Hospital Ulm

1. Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine

   Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo +15

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.244235

2. <i>IDH1</i>and<i>IDH2</i>Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With<i>NPM1</i>Mutation Without<i>FLT3</i>Internal Tandem Duplication

   Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik +11

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.430736

3. Acute Myeloid Leukemia

   Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield

   Sharh maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.430765

4. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

   Hartmut Döhner, Elihu H. Estey, Sergio Amadori +16

   Sharh maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.574567